|
Cut Cost of Doing Business
| |
Join the SoCalBio Group Purchasing Program to enjoy significant savings on lab supplies and equipment from
For more info, call SoCalBio at
800-418-7079 ext 3
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
August 5, 2013
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
enany@socalbio.org
www.socalbio.org
|
|
Featuring Next Gen. Medtech, Biotech & eHealth Companies
To sponsor or make a business presentation, contact SoCalBio at
|
|
IPO Market
|
Is 2013 Shaping Up as the Best Year for Biotech IPOs in More Than a Decade?
 Burrill & Company reports that the lif -science IPO market is heating up. Burrill notes that there are now 29 life sciences companies that have gone public this year--compared to 11 in all of last year--raising $5 billion compared to a paltry $771 million last year. Overall, it looks that 2013 is shaping up as one of the best years for life sciences fundraising in more than a decade ... Read more
|
|
New Funding
| |
BioBeats, a Los Angeles-Based Mobile Health Company, Raises $650,000 in Seed Funding
 BioBeats -- a startup that seeks merging entertainment and healthcare -- raised money from investors including Will Smith, Damon Wayans, Scooter Braun, Justin Boreta, entertainment lawyer Ken Hertz, AAM CEO Mark Beaven, Cantora Records, ENIAC Ventures, Zhen Fund, and angel investors Gotham Chopra and Kevin Colleran. www.biobeats.com
The Forest Lake-Based Revision Optics Closes a $55 Million Funding Round
 "We are clearly delighted to complete this strategic financing with such highly regarded healthcare venture investors," said John T. Kilcoyne (photo right), Revision Optics' President and Chief Executive Officer. "Participation by all of our existing investors, Canaan, ProQuest, InterWest and Domain, combined with the capital from new investors JJDC and RMI, provides our company with the necessary financial resources to carry us through the FDA PMA process for the Raindrop Near Vision Inlay and to expand our current commercial footprint outside the U.S.," he added ... Read Press Release
The Los Angeles-Based Meditope Biosciences Announces the Completion of a $3.6 Million Series A Round of Funding
 Meditope -- a spinoff of the City of Hope and alumnus of the 2012 SoCalBio Investor Conference -- has raised $3.6M in a Series A financing led by angel investors to advance its proprietary monoclonal antibody (mAb) linker technology platform. "We are grateful to have had the opportunity to be funded by angel investors, who include pioneers in the biotechnology industry and are supportive of our efforts to quickly advance the development of this exciting new technology platform into the clinic," said Stephanie Hsieh (photo right), the company's President & CEO and a leading member of the SoCalBio W3 Group ... Learn more about Meditope Biosciences
Second Sight Medical Products Files
to Raise $10.5 Million
 The Los Angeles-based medical device company is launching the Argus II. It is the first bionic eye that the FDA approved earlier this year. It was 20 years in the making. The device looks like a sunglass but incorporates a digital camera, which in turn communicates with an implant on the eye. It is aimed at patients suffering from late stage retinitis pigmentosa (RP) ... Read more
San Juan Capistrano-Based Startup Caymus Medical Seeks $10 Million
 Caymus -- a company seeking to develop devices for percutaneous intravascular access and guidewire placement -- has raised $3.9 million so far from 19 investors, according to the filing. Investors' names were not listed and the company didn't specify what it plans to do with the funds .. Read Announcement at MassDevice
|
|
New SoCalBio Members
|
AVI-SPL (Cypress)
AVI-SPL helps customers of all sizes and industries to develop their video communications strategies by providing services that assess, develop and support solutions. ... Learn more
Gordon L. Schooly, Ph.D., LLC (San Diego)
Provides g lobal regulatory and clinical development strategy and execution. FDA, EMA, Health Canada and Australia Health Authority representation. Biostatistics and clinical data management, electronic regulatory submissions including CDISC and C-Path, analytics support to government health agencies and private health care providers .. Learn more
Citrus College (Glendora)
A community college in the San Gabriel Valley ... Learn more
|
|
Register for SoCalBio Events
|
SoCalBio Workforce Summit & Job Fair
(Notice New Date and Location)
Building the Bioeconomy Talent Pipeline
August 21, 2013, 8 am to 4 pm
Van de Kamp Innovation Center
2930 Fletcher Drive and San Fernando Road,
Los Angeles CA 90065
We are delighted to announce the following
Luncheon Keynote Speaker
Cathleen Benko
Vice Chairman & Chief Talent Officer
Deloitte
|
|
Sponsored Events
|
October 8 - 9, 2013 in San Francisco, CA
-----------------------------------------------------------------------------------------
November 11 - 13 in Beijing, China
|
|
Medtech Trends
|
Medtech Market in Europe is Growing 5% Each Year
 With a €100-billion market size, medtech is looking even more promising across the pond. The recession may have hit some member states particularly hard, but there is still a lot of potential for development in hot-spot countries such as the UK, Switzerland, France, and Germany. The infographic below provides a snapshot of what medtech industry professionals are seeing in Europe ... See Infograph
|
|
Bionic Devices
|
Bionic Medical Devices: What's Holding Them Back?
 This MD+DI article contends that funding has been the main obstacle to bringing bionic technologies to market. The Los Angeles-based Second Sight is one the binic device companies that demonstrated success in closing the the gap between biological organs and limbs and their prosthetic counterparts. The bigger hurdle in briging products to market has been financial. Second Sight's Argus II is the culmination of more than two decades of research that Second Sight CEO Robert Greenberg started as a graduate student at Johns Hopkins University. The product is one of the lucky few to make it out of the lab ... Read more
|
|
Regenerative Medicine
| |
Avita Medical Enrolls First Patients In ReCell Trial For Chronic Leg Ulcers
 The Northridge-based Avita Medical announced the initial enrollment of three patients in the RESTORE trial, a multi-centre, randomized European clinical trial evaluating the use of ReCell Spray-on Skin in the management of patients with venous leg ulcers. The company believes the management and treatment of lower limb ulcers (LLUs) represents a large and growing market opportunity for ReCell ... Read Press Release
|
|
Epilepsy Trial
| |
NeuroSigma Commences Phase III Trial for its Epilepsy Treatment Device
 The Los Angeles-based NeuroSigma announced conditional approval by the U.S. Food and Drug Administration (FDA) of its Investigational Device Exemption (IDE) application to commence a Phase III pivotal trial of the Monarch eTNS System for treatment of drug resistant epilepsy. The Company is planning to conduct a multi-center trial at leading medical institutions in the U.S., Europe and Canada. The objective of the study is to evaluate the safety and effectiveness of the device and provide the basis for a Pre-Market Approval (PMA) application to the FDA ... Read Press Release
|
| Join SoCalBio | |
Become a SoCalBio Member and Save Money by Utlizing the SoCalBio Group Purchasing Program
|
| Jobs Available | |
Phenomenex (Torrance)
ResearchDx (Irvine)
Avita Medical (Northridge)
Aubrey Group (Irvine)
Second Sight Medical Products (Sylmar)
Alfred Mann Foundation for Scientific
Research (Santa Clarita)
WaveTec Vision (Aliso Viejo)
Response Genetics (Los Angeles)
Tribogenics (Marina del Rey)
Click to access more info
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
